Moderna, Inc. Investors: Company Investigated by the Portnoy Law Firm

莫德纳公司(Modelna,Inc.)投资者:波特诺伊律师事务所调查的公司

2020/05/27 18:25  Portnoy Law

LOS ANGELES, May 27, 2020 (GLOBE NEWSWIRE) --The Portnoy Law Firmadvises Moderna, Inc. ("Moderna") (NASDAQ: MRNA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorneyLesley F. Portnoy, by phone 310-692-8883 oremail: lesley@portnoylaw.com, to discuss their legal rights, including eligibility for appointment as a Lead Plaintiff.Click hereto join the case via www.portnoylaw.com. Lead Plaintiffs are appointed by the court to act as a fiduciary on behalf of other injured investors. Lead plaintiffs do not bear any direct cost or expense of the case, and are eligible to receive a monetary award for participating in the case.

The investigation focuses on whether the company and its executives misled investors concerning the viability of the Moderna’s lead drug candidate, a vaccine candidate against novel coronavirus. In addition, on May 27th, 2020, Statnews reported that five top executives of Moderna sold more than $89 million of stock this year, thereby directly benefiting from the allegedly misleading statements concerning the company’s vaccine.

Please visit ourwebsiteto review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.

Admitted CA and NY Bar

lesley@portnoylaw.com

310-692-8883

www.portnoylaw.com

Attorney Advertising

4203e30d-27ab-40a6-9d45-93140f6d30d3

洛杉矶,2020年5月27日(环球通讯社)-波特诺法律基金会建议现代公司。(“现代”)(纳斯达克股票代码:mRNA)投资者表示,公司已对可能的证券欺诈展开调查,并可能代表投资者提起集体诉讼。

鼓励投资者通过电话310-692-8883或电子邮件:Lesley@portnoylaw.com与律师Lesley F.Portnoy联系,讨论他们的合法权利,包括被任命为首席原告的资格。单击此处通过www.portnoylaw.com加入此案。主要原告由法院指定,代表其他受害投资者担任受托人。主要原告不承担案件的任何直接成本或费用,并有资格因参与案件而获得金钱奖励。

调查的重点是该公司及其高管在现代纳的主要候选药物(一种对抗新型冠状病毒的疫苗候选药物)的可行性方面是否误导了投资者。此外,2020年5月27日,Statnews报道称,Modelna的五名高管今年出售了超过8900万美元的股票,从而直接受益于有关该公司疫苗的所谓误导性陈述。

请访问我们的网站查看更多信息并提交您的交易信息。

波特诺伊律师事务所代表投资者起诉公司不当行为造成的索赔。该公司的创始合伙人已经为愤愤不平的投资者追回了55亿美元。律师广告。先前的结果不能保证类似的结果。

莱斯利·F·波特诺(Lesley F.Portnoy),Esq

加州和纽约酒吧入场

邮箱:Lesley@portnoylaw.com

310-692-8883

www.portnoylaw.com

律师广告

4203e30d-27ab-40a6-9d45-93140f6d30d3

免责声明:中文翻译由腾讯翻译君提供支持,富途对翻译信息的准确性或可靠性所造成的任何损失不承担任何责任。

风险提示:上文所示之作者或者嘉宾的观点,都有其特定立场,投资决策需建立在独立思考之上。富途将竭力但却不能保证以上内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。